
HSV
HSV inhibitors are compounds that target the Herpes Simplex Virus (HSV), which causes infections such as cold sores and genital herpes. These inhibitors can block viral entry, replication, or the assembly of new viral particles, helping to reduce the severity and duration of HSV infections. Research into HSV inhibitors is essential for developing antiviral therapies that can manage and treat both acute and latent HSV infections. At CymitQuimica, we offer a selection of HSV inhibitors to support your research in virology, antiviral therapy, and infectious disease.
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Valomaciclovir stearate REF: TM-T29093CAS: 195156-77-5 | 100% - 100% | 309.00 €~3,153.00 € | Mon 23 Jun 25 |
![]() | Omaciclovir REF: TM-T28234CAS: 124265-89-0 | 99.46% - 99.46% | 130.00 €~2,480.00 € | Mon 21 Jul 25 |
![]() | 17,17-Ethylendioxyandrost-5-en-3β-ol REF: TM-T200287CAS: 7745-40-6 | - - - | To inquire | Mon 21 Jul 25 |

Valomaciclovir stearate
Ref: TM-T29093
1mg | 309.00 € | ||
5mg | 933.00 € | ||
10mg | 1,254.00 € |

Omaciclovir
Ref: TM-T28234
1mg | 130.00 € | ||
25mg | 1,206.00 € | ||
50mg | 1,568.00 € | ||
100mg | 2,480.00 € |

17,17-Ethylendioxyandrost-5-en-3β-ol
Ref: TM-T200287
25mg | 1,444.00 € | ||
50mg | 1,882.00 € | ||
100mg | 2,375.00 € |